Your browser doesn't support javascript.
loading
Prevalence of hepatitis B and C viruses among migrant workers in Qatar.
Nasrallah, Gheyath K; Chemaitelly, Hiam; Ismail, Ahmed I A; Nizamuddin, Parveen B; Al-Sadeq, Duaa W; Shurrab, Farah M; Amanullah, Fathima H; Al-Hamad, Tasneem H; Mohammad, Khadija N; Alabdulmalek, Maryam A; Al Kahlout, Reham A; Al-Shaar, Ibrahim; Elshaikh, Manal A; Abouassali, Mazen N; Karimeh, Ibrahim W; Ali, Mutaz M; Ayoub, Houssein H; Abdeen, Sami; Abdelkarim, Ashraf; Daraan, Faisal; Ismail, Ahmed Ibrahim Hashim Elhaj; Mostafa, Nahid; Sahl, Mohamed; Suliman, Jinan; Tayar, Elias; Kasem, Hasan Ali; Agsalog, Meynard J A; Akkarathodiyil, Bassam K; Alkhalaf, Ayat A; Alakshar, Mohamed Morhaf M H; Al-Qahtani, Abdulsalam Ali A H; Al-Shedifat, Monther H A; Ansari, Anas; Ataalla, Ahmad Ali; Chougule, Sandeep; Gopinathan, Abhilash K K V; Poolakundan, Feroz J; Ranbhise, Sanjay U; Saefan, Saed M A; Thaivalappil, Mohamed M; Thoyalil, Abubacker S; Umar, Inayath M; Al Kuwari, Einas; Coyle, Peter; Jeremijenko, Andrew; Kaleeckal, Anvar Hassan; Abdul Rahim, Hanan F; Yassine, Hadi M; Al Thani, Asmaa A; Chaghoury, Odette.
  • Nasrallah GK; Biomedical Research Center, Qatar University, Doha, Qatar. gheyath.nasrallah@qu.edu.qa.
  • Chemaitelly H; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, 2713, Doha, Qatar. gheyath.nasrallah@qu.edu.qa.
  • Ismail AIA; Infectious Disease Epidemiology Group, Weill Cornell Medicine-Qatar, Cornell University, P.O. Box 24144, Doha, Qatar.
  • Nizamuddin PB; World Health Organization Collaborating Centre for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation-Education City, Doha, Qatar.
  • Al-Sadeq DW; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Shurrab FM; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
  • Amanullah FH; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Al-Hamad TH; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, 2713, Doha, Qatar.
  • Mohammad KN; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Alabdulmalek MA; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Al Kahlout RA; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, 2713, Doha, Qatar.
  • Al-Shaar I; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Elshaikh MA; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, 2713, Doha, Qatar.
  • Abouassali MN; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Karimeh IW; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Ali MM; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Ayoub HH; Biomedical Research Center, Qatar University, Doha, Qatar.
  • Abdeen S; Department of Biomedical Science, College of Health Sciences, QU Health, Qatar University, 2713, Doha, Qatar.
  • Abdelkarim A; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
  • Daraan F; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
  • Ismail AIHE; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
  • Mostafa N; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
  • Sahl M; Laboratory Section, Medical Commission Department, Ministry of Public Health, Doha, Qatar.
  • Suliman J; Mathematics Program, Department of Mathematics and Statistics, College of Arts and Sciences, Qatar University, Doha, Qatar.
  • Tayar E; Hamad Medical Corporation, Doha, Qatar.
  • Kasem HA; Hamad Medical Corporation, Doha, Qatar.
  • Agsalog MJA; Ministry of Public Health, Doha, Qatar.
  • Akkarathodiyil BK; Ministry of Public Health, Doha, Qatar.
  • Alkhalaf AA; Ministry of Public Health, Doha, Qatar.
  • Alakshar MMMH; Hamad Medical Corporation, Doha, Qatar.
  • Al-Qahtani AAAH; Ministry of Public Health, Doha, Qatar.
  • Al-Shedifat MHA; Hamad Medical Corporation, Doha, Qatar.
  • Ansari A; Hamad Medical Corporation, Doha, Qatar.
  • Ataalla AA; Qatar Red Crescent Society, Doha, Qatar.
  • Chougule S; Qatar Red Crescent Society, Doha, Qatar.
  • Gopinathan AKKV; Qatar Red Crescent Society, Doha, Qatar.
  • Poolakundan FJ; Qatar Red Crescent Society, Doha, Qatar.
  • Ranbhise SU; Qatar Red Crescent Society, Doha, Qatar.
  • Saefan SMA; Qatar Red Crescent Society, Doha, Qatar.
  • Thaivalappil MM; Qatar Red Crescent Society, Doha, Qatar.
  • Thoyalil AS; Qatar Red Crescent Society, Doha, Qatar.
  • Umar IM; Qatar Red Crescent Society, Doha, Qatar.
  • Al Kuwari E; Qatar Red Crescent Society, Doha, Qatar.
  • Coyle P; Qatar Red Crescent Society, Doha, Qatar.
  • Jeremijenko A; Qatar Red Crescent Society, Doha, Qatar.
  • Kaleeckal AH; Qatar Red Crescent Society, Doha, Qatar.
  • Abdul Rahim HF; Qatar Red Crescent Society, Doha, Qatar.
  • Yassine HM; Qatar Red Crescent Society, Doha, Qatar.
  • Al Thani AA; Qatar Red Crescent Society, Doha, Qatar.
  • Chaghoury O; Qatar Red Crescent Society, Doha, Qatar.
Sci Rep ; 14(1): 11275, 2024 05 17.
Article en En | MEDLINE | ID: mdl-38760415
ABSTRACT
Limited data exist on viral hepatitis among migrant populations. This study investigated the prevalence of current hepatitis B virus (HBV) infection and lifetime hepatitis C virus (HCV) infection among Qatar's migrant craft and manual workers (CMWs), constituting 60% of the country's population. Sera collected during a nationwide COVID-19 population-based cross-sectional survey on CMWs between July 26 and September 9, 2020, underwent testing for HBsAg and HCV antibodies. Reactive samples underwent confirmatory testing, and logistic regression analyses were employed to explore associations with HBV and HCV infections. Among 2528 specimens tested for HBV infection, 15 were reactive, with 8 subsequently confirmed positive. Three samples lacked sufficient sera for confirmatory testing but were included in the analysis through multiple imputations. Prevalence of current HBV infection was 0.4% (95% CI 0.2-0.7%). Educational attainment and occupation were significantly associated with current HBV infection. For HCV infection, out of 2607 specimens tested, 46 were reactive, and 23 were subsequently confirmed positive. Prevalence of lifetime HCV infection was 0.8% (95% CI 0.5-1.2%). Egyptians exhibited the highest prevalence at 6.5% (95% CI 3.1-13.1%), followed by Pakistanis at 3.1% (95% CI 1.1-8.0%). Nationality, geographic location, and occupation were significantly associated with lifetime HCV infection. HBV infection is relatively low among CMWs, while HCV infection falls within the intermediate range, both compared to global and regional levels.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Migrantes / Hepatitis C / Hepatitis B Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Migrantes / Hepatitis C / Hepatitis B Límite: Adolescent / Adult / Female / Humans / Male / Middle aged País como asunto: Asia Idioma: En Año: 2024 Tipo del documento: Article